Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Virology|December 1, 1993
Epstein-Barr virus recombinants from overlapping cosmid fragmentsB Tomkinson, E Robertson, R Yalamanchili, et al.
The Biochemical Journal|November 15, 1987
Supramolecular structure of tripeptidyl peptidase II from human erythrocytes as studied by electron microscopy, and its correlation to enzyme activityE Macpherson, B Tomkinson, R M Bålöw, et al.
Journal of Virology|April 1, 1993
The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitroR Longnecker, C L Miller, X Q Miao, et al.
Journal of Virology|August 1, 1993
Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2BR Longnecker, C L Miller, B Tomkinson, et al.
The Journal of Investigative Dermatology|March 12, 2002
Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesionsW J Lin, D A Norris, M Achziger, et al.
Journal of Virology|May 1, 1995
Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappaE S Robertson, S Grossman, E Johannsen, et al.
Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology|September 1, 1993
Assignment of the linkage group EAM-TYRP2-TPP2 to chromosome 11 in pigs by in situ hybridization mapping of the TPP2 geneB P Chowdhary, M Johansson, F Gu, et al.
ESMO Open|February 22, 2025
A phase I, first-in-human trial of KO-947, an ERK1/2 inhibitor, in patients with advanced solid tumorsA M Schram, V Boni, A A Adjei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecanD L Emerson, R Bendele, E Brown, et al.
Pageof 3